Endothelial Progenitor Cell Dysfunction in Diabetes Mellitus Type-2: Focus on Nitric Oxide System

QR Code

Endothelial Progenitor Cell Dysfunction in Diabetes Mellitus Type-2: Focus on Nitric Oxide System

None

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Kaituhi matua:	Hamed, Saher
Hōputu:	Tāhiko Wāhanga pukapuka
Reo:	Ingarihi
I whakaputaina:	IntechOpen 2011
Ngā marau:	Health Sciences
Urunga tuihono:	https://www.intechopen.com/chapters/19817
Tags:	Tāpirihia he Tūtohu No Tags, Be the first to tag this record!

Ngā tūemi rite

Nitric oxide role and endothelial dysfunction development in diabetes mellitus
mā: S. G. Dzugkoev, me ētahi atu.
I whakaputaina: (1970-01-01)

The effects of exercise intervention on the function of endothelial progenitor cells in atherosclerotic mice with type 2 diabetes mellitus
mā: Zheng HUANG, me ētahi atu.
I whakaputaina: (2025-06-01)

The Role of Endothelial Progenitor Cells (EPCs) and Circulating Endothelial Cells (CECs) as Early Biomarkers of Endothelial Dysfunction in Children with Newly Diagnosed Type 1 Diabetes
mā: Milena Jamiołkowska-Sztabkowska, me ētahi atu.
I whakaputaina: (2025-07-01)

Disturbance of Arginase Activity and Nitric Oxide Levels in Iraqi Type 2 Diabetes Mellitus
mā: Baghdad Science Journal
I whakaputaina: (2018-06-01)

ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS
mā: M. M. Petina, me ētahi atu.
I whakaputaina: (2011-04-01)

Oxidative stress and endothelial dysfunction correction with ACE inhibitor therapy in patients with myocardial infarction and Type 2 diabetes mellitus
mā: V. S. Zadionchenko, me ētahi atu.
I whakaputaina: (2008-10-01)

The role of nitric oxide in improving endothelial function andcardiovascular health: focus on nebivolol
mā: G. L. Bakris, me ētahi atu.
I whakaputaina: (2011-04-01)

ACTIVITY MODULATION OF VARIOUS NITRIC OXIDE SYNTASES AS AN APPROACH TO ENDOTHELIAL DYSFUNCTION THERAPY
mā: D. V. Kurkin, me ētahi atu.
I whakaputaina: (2022-05-01)

The results of correction of endothelial dysfunction in type 2 diabetes mellitus in patients with diabetic retinopathy and associated hypertension
mā: L. K. Moshetova, me ētahi atu.
I whakaputaina: (2014-07-01)

Endothelial Nitric Oxide Synthase, Nitric Oxide and Metabolic Disturbances in the Vascular System
mā: Lutosławska, Grażyna
I whakaputaina: (2012)

Endothelial Progenitor Cell in Cardiovascular Diseases
mā: Huang, Po-Hsun
I whakaputaina: (2012)

Endothelial Dysfunction and Therapeutic Intervention in Type 2 Diabetes
mā: Páez, Fernando Grover
I whakaputaina: (2011)

Endothelial Dysfunction Diagnostic “Platform” in patients with diabetes mellitus
mā: I. A. Khripun, me ētahi atu.
I whakaputaina: (2022-03-01)

Role of nitric oxide and endothelial NO synthase in carcinogenesis
mā: V. P. Deryagina, me ētahi atu.
I whakaputaina: (2021-07-01)

Correction of endothelial dysfunction and microcirculation disturbances in patients with essential arterial hypertension and Type 2 diabetes mellitus
mā: N. V. Yakutina
I whakaputaina: (2007-12-01)

Genetics of Endothelial Damage Associated to Diabetes Mellitus Type 2
mā: García, Lorena, me ētahi atu.
I whakaputaina: (2011)

Thyroid Dysfunction in Patients with Type 2 Diabetes Mellitus
mā: Annia Quintana Marrero, me ētahi atu.
I whakaputaina: (2020-09-01)

The impact of perindopril and metformin on the markers of endothelial dysfunction in rats with acute intracerebral hemorrhage and type 2 diabetes mellitus
mā: V.I. Zhyliuk, me ētahi atu.
I whakaputaina: (2021-12-01)

Role of endothelial dysfunction in the pathogenesis of diabetic retinopathy in patients with type 2 diabetes
mā: I. V. Vorobyeva, me ētahi atu.
I whakaputaina: (2014-07-01)

Relationship of endothelial dysfunction with degree of renal function damage and lipidemic profile in patients with type 2 diabetes mellitus and hypertension.
mā: N. O. Pertseva
I whakaputaina: (2014-09-01)

Endothelial Progenitor Cells: New Targets to Control Autoimmune Disorders
mā: Brice, Sarah L., me ētahi atu.
I whakaputaina: (2011)

The Role of Endothelial Progenitor Cell in Cardiovascular Disease Risk Factors
mā: Rahmawati Minhajat, me ētahi atu.
I whakaputaina: (2016-05-01)

The Role of Endothelial Progenitor Cell in Cardiovascular Disease Risk Factors
mā: Rahmawati Minhajat, me ētahi atu.
I whakaputaina: (2016-05-01)

The Role of Endothelial Progenitor Cell in Cardiovascular Disease Risk Factors
mā: Rahmawati Minhajat, me ētahi atu.
I whakaputaina: (2016-05-01)

Nebivolol effects on myocardial remodelling, inflammation markers and endothelial dysfunction in chronic heart failure patients with or without Type 2 diabetes mellitus
mā: Yu. N. Belenkov, me ētahi atu.
I whakaputaina: (2011-02-01)

Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity
mā: E. V. Eliseeva, me ētahi atu.
I whakaputaina: (1970-01-01)

Regulation of Endothelial Progenitor Cell Function by Plasma Kallikrein-Kinin System
mā: Wu, Yi, me ētahi atu.
I whakaputaina: (2011)

Endothelial Progenitor Cell Number: A Convergence of Cardiovascular Risk Factors
mā: Hoenig, Michel R., me ētahi atu.
I whakaputaina: (2012)

Corneal Endothelial Cell Loss Following Cataract Surgery in Patients with Type 2 Diabetes Mellitus: A Comprehensive Review
mā: Mădălina-Casiana Salavat, me ētahi atu.
I whakaputaina: (2025-07-01)

Nitric Oxide Synthase and Oxidative Stress: Regulation of Nitric Oxide Synthase
mā: Ali, Ehab M. M., me ētahi atu.
I whakaputaina: (2012)

ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
mā: M. E. Statsenko, me ētahi atu.
I whakaputaina: (2015-09-01)

EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE
mā: G. A. Batrak, me ētahi atu.
I whakaputaina: (2015-09-01)

The role of endothelial dysfunction and subclinical inflammation in the development of obstetric and perinatal complications in diabetes mellitus patients
mā: Yu. A. Dudareva, me ētahi atu.
I whakaputaina: (2021-08-01)

Plasma concentrations of endothelial nitric oxide synthase (enos) after different physical exercises
mā: E. Yu. Dyakova, me ētahi atu.
I whakaputaina: (2017-04-01)

POLYMORPHISMS OF ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE AS PREDICTORS OF WOLFF-PARKINSON-WHITE SYNDROME
mā: G. V. Matyushin, me ētahi atu.
I whakaputaina: (2017-11-01)

Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellitus
mā: A. V. Zhito, me ētahi atu.
I whakaputaina: (2020-01-01)

Endothelial dysfunction in arterial hypertension: focus on the combination of trandolapril and verapamil
mā: V. I. Makolkin
I whakaputaina: (2010-08-01)

Type 2 diabetes mellitus and gout
mā: O. V. Zhelyabina, me ētahi atu.
I whakaputaina: (2021-10-01)

HYPERTENSION AND DIABETES MELLITUS TYPE 2
mā: M. E. Statsenko, me ētahi atu.
I whakaputaina: (2018-05-01)

Plasma Total Nitric Oxide and Endothelial Constitutive Nitric Oxide Synthase (ecNOS) Inron 4 Gene Polymorphism: A Study in Children with Chronic Kidney Disease
mā: Elshamaa, Manal F., me ētahi atu.
I whakaputaina: (2011)